0
0
10/23/22 at 8:30pm
Organization
MedPage Today
Author
Ingrid Hein
26 words
0
Comments
Seroprotection seen in 100% of participants after three doses of Heplisav-B vaccine
You are the first to view
https://www.medpagetoday.com/meetingcoverage/idweek/101367
Create an account
or login to join the discussion